Ypsomed

0QLQ.L | LSE | 0 Obserwujący

CHF 416.00

-0.36%

-CHF 1.50

Obserwuj

Overview Metrics Financials

Fair Price

PWP 532.23

Overvalued by 18.8%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Ypsomed Holding AG is a Swiss technology company specializing in the development and manufacturing of drug delivery devices, primarily for diabetes and other chronic conditions. Founded in 2003, the company is now one of the leading global manufacturers of insulin pumps, injection pen systems, and other devices that make it easier for patients to manage and administer their treatment. Ypsomed focuses on innovations in biologic drug delivery and the development of new devices to improve patients' quality of life, such as automated insulin delivery systems. The company operates globally, with its products used in many countries.

Feed

There are no posts to show right now.

Ypsomed

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?